2 nd Brazilian Consensus on Chagas Disease, 2015
Tóm tắt
Từ khóa
Tài liệu tham khảo
2012
2013
Dias JC, 2002, The impact of Chagas disease control in Latin America: a review, Mem Inst Oswaldo Cruz, 97, 603, 10.1590/S0074-02762002000500002
Coura JR, 2009, Epidemiology, control and surveillance of Chagas disease: 100 years after its discovery, Mem Inst Oswaldo Cruz, 104, 31, 10.1590/S0074-02762009000900006
2015, Chagas disease in Latin America: an epidemiological update based on 2010 estimates, Wkly Epidemiol Rec, 90, 33
Moncayo A, 2009, Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy, Mem Inst Oswaldo Cruz, 104, 17, 10.1590/S0074-02762009000900005
Schmunis GA, 2010, Chagas disease: a Latin American health problem becoming a world health problem, Acta Trop, 115, 14, 10.1016/j.actatropica.2009.11.003
2013
Hotez PJ, 2013, An unfolding tragedy of Chagas disease in North America, PLoS Negl Trop Dis, 7, 10.1371/journal.pntd.0002300
Dias JCP, 2013, Human chagas disease and migration in the context of globalization: some particular aspects, J Trop Med
Coura JR, 2014, Ecoepidemiology, short history and control of Chagas disease in the endemic countries and the new challenge for non-endemic countries, Mem Inst Oswaldo Cruz, 109, 856, 10.1590/0074-0276140236
2014
Requena-Méndez A, 2015, Prevalence of Chagas disease in Latin-American migrants living in Europe: a systematic review and meta-analysis, PLoS Negl Trop Dis, 9, 10.1371/journal.pntd.0003540
2015
Ramos Júnior AN, 2009, Chagas' disease: past, present and future, Cad Saude Colet, 17, 787
Strasen J, 2014, Epidemiology of Chagas disease in Europe: many calculations, little knowledge, Clin Res Cardiol, 103, 1, 10.1007/s00392-013-0613-y
2006
Dias JCP, 2007, Southern Cone Initiative for the elimination of domestic populations of Triatoma infestans and the interruption of transfusion Chagas disease: historical aspects, present situation, and perspectives, Mem Inst Oswaldo Cruz, 102, 11, 10.1590/S0074-02762007005000092
Prata A, 2001, Clinical and epidemiological aspects of Chagas disease, Lancet Infect Dis, 1, 92, 10.1016/S1473-3099(01)00065-2
2005, Consenso Brasileiro em Doença de Chagas, Rev Soc Bras Med Trop, 38, 1
2009
Silveira AC, 2011, O controle da transmissão vetorial, Rev Soc Bras Med Trop, 44, 52, 10.1590/S0037-86822011000800009
Coura JR, 2015, The main sceneries of Chagas disease transmission. The vectors, blood and oral transmissions: a comprehensive review, Mem Inst Oswaldo Cruz, 110, 277, 10.1590/0074-0276140362
Victora CG, 2003, Applying an equity lens to child health and mortality: more of the same is not enough, Lancet, 362, 233, 10.1016/S0140-6736(03)13917-7
Zingales B, 2009, A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI, Mem Inst Oswaldo Cruz, 104, 1051, 10.1590/S0074-02762009000700021
Zingales B, 2014, Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity, Mem Inst Oswaldo Cruz, 109, 828, 10.1590/0074-0276140156
Messenger LA, 2015, Between a bug and a hard place: Trypanosoma cruzi genetic diversity and the clinical outcomes of Chagas disease, Expert Rev Anti Infect Ther, 13, 995, 10.1586/14787210.2015.1056158
Victora CG, 2011, Health conditions and health-policy innovations in Brazil: the way forward, Lancet, 377, 2042, 10.1016/S0140-6736(11)60055-X
Barreto ML, 2011, Successes and failures in the control of infectious diseases in Brazil: social and environmental context, policies, interventions, and research needs, Lancet, 377, 1877, 10.1016/S0140-6736(11)60202-X
Mendes EV, 2012
2015
Camargo ME, 1984, Serological survey of the prevalence of Chagas' infection in Brazil, 1975/1980, Rev Inst Med Trop São Paulo, 26, 192
Silveira AC, 2011, O Inquérito de soroprevalência da infecção chagásica humana (1975-1980), Rev Soc Bras Med Trop, 44, 33, 10.1590/S0037-86822011000800006
Akhavan D, 1998
Martins-Melo FR, 2014, Prevalence of Chagas disease in Brazil: a systematic review and meta-analysis, Acta Trop, 130, 167, 10.1016/j.actatropica.2013.10.002
Hotez PJ, 2014, Brazil's neglected tropical diseases: an overview and a report card, Microbes Infect, 16, 601, 10.1016/j.micinf.2014.07.006
Bern C, 2011, Montgomery SP. Trypanosoma cruzi and Chagas disease in the United States, Clin Microbiol Rev, 24, 655, 10.1128/CMR.00005-11
Dias JC, 2014, The present situation, challenges, and perspectives regarding the production and utilization of effective drugs against human Chagas disease, Rev Soc Bras Med Trop, 47, 123, 10.1590/0037-8682-0248-2013
2014
2013
Bern C, 2009, Congenital Trypanosoma cruzi transmission in Santa Cruz, Bolivia, Clin Infect Dis, 49, 1667, 10.1086/648070
Ventura-Garcia L, 2013, Socio-cultural aspects of Chagas disease: a systematic review of qualitative research, PLoS Negl Trop Dis, 7, 10.1371/journal.pntd.0002410
Bern C, 2009, An estimate of the burden of Chagas disease in the United States, Clin Infect Dis, 49, e52, 10.1086/605091
Buekens P, 2008, Mother-to-child transmission of Chagas' disease in North America: why don't we do more?, Matern Child Health J, 12, 283, 10.1007/s10995-007-0246-8
Silveira C, 2013, Living conditions and access to health services by Bolivian immigrants in the city of São Paulo, Brazil, Cad Saude Publica, 29, 2017, 10.1590/0102-311X00113212
Martes ACB, 2013, Acesso dos imigrantes bolivianos aos serviços públicos de saúde na cidade de São Paulo, Saude Soc, 22, 351, 10.1590/S0104-12902013000200008
Almeida EA, 2010, Chagas' disease and HIV co-infection in patients without effective antiretroviral therapy: prevalence, clinical presentation and natural history, Trans R Soc Trop Med Hyg, 104, 447, 10.1016/j.trstmh.2010.02.004
Almeida EA, 2011, Co-infection Trypanosoma cruzi/HIV: systematic review (1980-2010), Rev Soc Bras Med Trop, 44, 762, 10.1590/S0037-86822011000600021
2014, Ministério da Saúde (BR). Secretaria de Vigilância em Saúde. Departamento de DST, Aids e Hepatites Virais, Bol Epidemiol, 3, 1
2014
2006, Recomendações para diagnóstico, tratamento e acompanhamento da co-infecção Trypanosoma cruzi: vírus da imunodeficiência humana, Rev Soc Bras Med Trop, 39, 392, 10.1590/S0037-86822006000400017
Martins-Melo FR, 2012, Mortality related to Chagas disease and HIV/AIDS coinfection in Brazil, J Trop Med, 2012, 534649
Ramos Júnior AN, 2004, Inclusão da reativação da doença de Chagas como uma condição definidora de AIDS para fins de vigilância epidemiológica no Brasil, Rev Soc Bras Med Trop, 37, 192, 10.1590/S0037-86822004000200018
2015, Doença de Chagas aguda no Brasil: série histórica de 2000 a 2013, Bol Epidemiol, 46, 1
Martins-Melo FR, 2012, Multiple causes of death related to Chagas' disease in Brazil, 1999 to 2007, Rev Soc Bras Med Trop, 45, 591, 10.1590/S0037-86822012000500010
Martins-Melo FR, 2012, Mortality due to Chagas disease in Brazil from 1979 to 2009: trends and regional differences, J Infect Dev Ctries, 6, 817, 10.3855/jidc.2459
Drumond JAG, 2006, Internal migration and distribution of Chagas disease mortality, Brazil, 1981-1998, Cad Saude Publica, 22, 2131
Martins-Melo FR, 2012, Epidemiology of mortality related to Chagas' disease in Brazil, 1999-2007, PLoS Negl Trop Dis, 6
Martins-Melo FR, 2012, Mortality of Chagas' disease in Brazil: spatial patterns and definition of high-risk areas, Trop Med Int Health, 17, 1066, 10.1111/j.1365-3156.2012.03043.x
Santo AH, 2009, Tendência da mortalidade relacionada à doença de Chagas, Estado de São Paulo, Brasil, 1985 a 2006: estudo usando causas múltiplas de morte, Rev Panam Salud Publica, 26, 299, 10.1590/S1020-49892009001000003
Nóbrega AA, 2014, Mortality due to Chagas disease in Brazil according to a specific cause, Am J Trop Med Hyg, 91, 528, 10.4269/ajtmh.13-0574
Alves RM, 2009, Chagas' disease and ageing: the coexistence of other chronic diseases with Chagas' disease in elderly patients, Rev Soc Bras Med Trop, 42, 622, 10.1590/S0037-86822009000600002
Lima-Costa MF, 2010, Chagas disease and mortality in old age as an emerging issue: 10 year follow-up of the Bambuí population-based cohort study (Brazil), Int J Cardiol, 145, 362, 10.1016/j.ijcard.2010.02.036
Silveira AC, 2011, Os novos desafios e perspectivas futuras do controle, Rev Soc Bras Med Trop, 44, 122, 10.1590/S0037-86822011000800016
Passos ADC, 2011, Síntese dos resultados dos inquéritos nacionais, Rev Soc Bras Med Trop, 44, 47, 10.1590/S0037-86822011000800008
Vinhaes MC, 2014, Assessing the vulnerability of Brazilian municipalities to the vectorial transmission of Trypanosoma cruzi using multi-criteria decision analysis, Acta Trop, 137, 105, 10.1016/j.actatropica.2014.05.007
Ramos Júnior AN, 2001, Os diferentes significados da certificação conferida ao Brasil como estando livre da doença de Chagas, Cad Saude Publica, 17, 1403, 10.1590/S0102-311X2001000600011
Abad-Franch F, 2013, Certifying the interruption of Chagas disease transmission by native vectors: cui bono?, Mem Inst Oswaldo Cruz, 108, 251, 10.1590/0074-0276108022013022
Valença-Barbosa C, 2014, Modeling disease vector occurrence when detection is imperfect II: drivers of site-occupancy by synanthropic Triatoma brasiliensis in the Brazilian northeast, PLoS Negl Trop Dis, 8, 10.1371/journal.pntd.0002861
Abad-Franch F, 2014, All that glisters is not gold: sampling-process uncertainty in disease-vector surveys with false-negative and false-positive detections, PLoS Negl Trop Dis, 8, 10.1371/journal.pntd.0003187
Salvatella R, 2014, Interruption of vector transmission by native vectors and "the art of the possible", Mem Inst Oswaldo Cruz, 109, 122, 10.1590/0074-0276140338
Maegawa FA, 2003, Autochthonous Chagas' disease in Santa Catarina State, Brazil: report of the first case of digestive tract involvement, Rev Soc Bras Med Trop, 36, 609, 10.1590/S0037-86822003000500011
Santos CB, 2005, Peridomiciliary colonies of Triatoma vitticeps (Stal, 1859) (Hemiptera, Reduviidae, Triatominae) infected with Trypanosoma cruzi in rural areas of the state of Espírito Santo, Brazil, Mem Inst Oswaldo Cruz, 100, 471, 10.1590/S0074-02762005000500004
Lorosa ES, 2008, Foco de doença de Chagas em São Fidélis, no estado do Rio de Janeiro, Rev Soc Bras Med Trop, 41, 419, 10.1590/S0037-86822008000400020
Shikanai-Yasuda MA, 2012, Oral transmission of Chagas disease, Clin Infect Dis, 54, 845, 10.1093/cid/cir956
Sangenis LH, 2015, Autochthonous transmission of Chagas disease in Rio de Janeiro State, Brazil: a clinical and eco-epidemiological study, BMC Infect Dis, 15, 4, 10.1186/s12879-014-0732-8
Xavier SC, 2012, Lower richness of small wild mammal species and Chagas disease risk, PLoS Negl Trop Dis, 6, 10.1371/journal.pntd.0001647
Xavier SC, 2014, Distantiae transmission of Trypanosoma cruzi: a new epidemiological feature of acute Chagas disease in Brazil, PLoS Negl Trop Dis, 8, 10.1371/journal.pntd.0002878
Roque AL, 2013, Trypanosoma cruzi among wild and domestic mammals in different areas of the Abaetetuba municipality (Pará State, Brazil), an endemic Chagas disease transmission area, Vet Parasitol, 193, 71, 10.1016/j.vetpar.2012.11.028
Roque AL, 2008, Trypanosoma cruzi transmission cycle among wild and domestic mammals in three areas of orally transmitted Chagas disease outbreaks, Am J Trop Med Hyg, 79, 742, 10.4269/ajtmh.2008.79.742
Abad-Franch F, 2010, Modeling disease vector occurrence when detection is imperfect: infestation of Amazonian palm trees by triatomine bugs at three spatial scales, PLoS Negl Trop Dis, 4, 10.1371/journal.pntd.0000620
Abad-Franch F, 2010, Research needs for Chagas disease prevention, Acta Trop, 115, 44, 10.1016/j.actatropica.2010.03.002
Padilla-Torres SD, 2013, Modeling dengue vector dynamics under imperfect detection: three years of site-occupancy by Aedes aegypti and Aedes albopictus in urban Amazonia, PLoS One, 8
Abad-Franch F, 2011, Community participation in Chagas disease vector surveillance: systematic review, PLoS Negl Trop Dis, 5, 10.1371/journal.pntd.0001207
Roux E, 2011, Spatial patterns and eco-epidemiological systems--part II: characterising spatial patterns of the occurrence of the insect vectors of Chagas disease based on remote sensing and field data, Geospat Health, 6, 53, 10.4081/gh.2011.157
Roux E, 2011, Spatial patterns and eco-epidemiological systems--part I: multi-scale spatial modelling of the occurrence of Chagas disease insect vectors, Geospat Health, 6, 41, 10.4081/gh.2011.156
Mougabure-Cueto G, 2015, Insecticide resistance in vector Chagas disease: evolution, mechanisms and management, Acta Trop, 149, 70, 10.1016/j.actatropica.2015.05.014
Pessoa GCA, 2015, Standardization of laboratory bioassays for the study of Triatoma sordida susceptibility to pyrethroid insecticides, Parasit Vectors, 8, 109, 10.1186/s13071-015-0726-4
Pessoa GCA, 2015, Toxicological profile of deltamethrin in Triatoma brasiliensis (Hemiptera: Reduviidae) in State of Ceará, Northeastern Brazil, Rev Soc Bras Med Trop, 48, 39, 10.1590/0037-8682-0010-2015
Pinto AYN, 2008, Fase aguda da doença de Chagas na Amazônia brasileira: estudo de 233 casos do Pará, Amapá e Maranhão observados entre 1988 e 2005, Rev Soc Bras Med Trop, 41, 602, 10.1590/S0037-86822008000600011
Nóbrega AA, 2009, Oral transmission of Chagas disease by consumption of açaí palm fruit, Brazil, Emerg Infect Dis, 15, 653, 10.3201/eid1504.081450
Dias JCP, 2011, Prevenção referente às modalidades alternativas de transmissão do Trypanosoma cruzi no Brasil, Rev Soc Bras Med Trop, 44, 68, 10.1590/S0037-86822011000800011
Dias JCP, 2006, Notas sobre o Trypanosoma cruzi e suas características bio-ecológicas, como agente de enfermidades transmitidas por alimentos, Rev Soc Bras Med Trop, 39, 370, 10.1590/S0037-86822006000400010
Dias JCP, 1998, Controle da transmissão transfusional da doença de Chagas na Iniciativa do Cone Sul, Rev Soc Bras Med Trop, 31, 373, 10.1590/S0037-86821998000400007
Moraes-Souza H, 2011, Controle da transmissão transfusional, Rev Soc Bras Med Trop, 44, 64, 10.1590/S0037-86822011000800010
2004
2004
Angheben A, 2015, Chagas disease and transfusion medicine: a perspective from non-endemic countries, Blood Transfus, 13, 540
Pinazo MJ, 2011, Recommendations for management of Chagas disease in organ and hematopoietic tissue transplantation programs in nonendemic areas, Transplant Rev (Orlando), 25, 91, 10.1016/j.trre.2010.12.002
Ostermayer AL, 2011, O inquérito nacional de soroprevalência de avaliação do controle da doença de Chagas no Brasil (2001-2008), Rev Soc Bras Med Trop, 44, 108, 10.1590/S0037-86822011000800015
Torrico F, 2004, Maternal Trypanosoma cruzi infection, pregnancy outcome, morbidity, and mortality of congenitally infected and non-infected newborns in Bolivia, Am J Trop Med Hyg, 70, 201, 10.4269/ajtmh.2004.70.201
Salas NA, 2007, Risk factors and consequences of congenital Chagas disease in Yacuiba, South Bolivia, Trop Med Int Health, 12, 1498, 10.1111/j.1365-3156.2007.01958.x
Carlier Y, 2011, Congenital Chagas disease: recommendations for diagnosis, treatment and control of newborns, siblings and pregnant women, PLoS Negl Trop Dis, 5, 10.1371/journal.pntd.0001250
Howard EJ, 2014, Frequency of the congenital transmission of Trypanosoma cruzi: a systematic review and meta-analysis, BJOG, 121, 22, 10.1111/1471-0528.12396
Martins-Melo FR, 2014, Prevalence of Chagas disease in pregnant women and congenital transmission of Trypanosoma cruzi in Brazil: a systematic review and meta-analysis, Trop Med Int Health, 19, 943, 10.1111/tmi.12328
Gontijo ED, 2009, Triagem neonatal da infecção pelo Trypanosoma cruzi em Minas Gerais, Brasil: transmissão congênita e mapeamento das áreas endêmicas, Epidemiol Serv Saude, 18, 243
Luquetti AO, 2015, Congenital transmission of Trypanosoma cruzi in central Brazil. A study of 1,211 individuals born to infected mothers, Mem Inst Oswaldo Cruz, 110, 369, 10.1590/0074-02760140410
Sosa-Estani S, 2009, Etiological treatment of young women infected with Trypanosoma cruzi, and prevention of congenital transmission, Rev Soc Bras Med Trop, 42, 484, 10.1590/S0037-86822009000500002
Herwaldt BL, 2001, Laboratory-acquired parasitic infections from accidental exposures, Clin Microbiol Rev, 14, 659, 10.1128/CMR.14.3.659-688.2001
Mahoney RT, 2006, Global Health Innovation System (GHIS), Innovation Strategy Today, 2, 1
Norman FF, 2013, Chagas disease and breast-feeding, Emerg Infect Dis, 19, 1561, 10.3201/eid1910.130203
Gebrekristos HT, 2014, Mother-to-Child transmission of Trypanosoma cruzi, J Ped Infect Dis Soc, 3, S36, 10.1093/jpids/piu059
De Rissio AM, 2010, Congenital Trypanosoma cruzi infection. Efficacy of its monitoring in an Urban Reference Health Center in non-endemic area of Argentina, Am J Trop Med Hyg, 82, 838, 10.4269/ajtmh.2010.08-0383
González-Tomé MI, 2013, Recomendaciones para el diagnóstico, seguimiento y tratamiento de la embarazada y del niño con enfermedad de Chagas, Enferm Infecc Microbiol Clin, 31, 535, 10.1016/j.eimc.2012.09.010
Carlier Y, 2015, Congenital Chagas disease: an update, Mem Inst Oswaldo Cruz, 110, 363, 10.1590/0074-02760140405
Russomando G, 2005, Implementación y evaluación de un sistema localmente sustentable de diagnóstico prenatal que permite detectar casos de transmisión congénita de la enfermedad de Chagas en zonas endêmicas del Paraguay, Rev Soc Bras Med Trop, 38, 49
Brutus L, 2010, Detectable Trypanosoma cruzi parasitemia during pregnancy and delivery as a risk factor for congenital Chagas disease, Am J Trop Med Hyg, 83, 1044, 10.4269/ajtmh.2010.10-0326
1999, Tratamiento etiológico de la enfermidad de Chagas: conclusiones de reunión de especialistas, Rev Patol Trop, 28, 247
Fabbro DL, 2007, Trypanocide treatment among adults with chronic Chagas disease living in Santa Fe City (Argentina), over a mean follow-up of 21 years: parasitological, serological and clinical evolution, Rev Soc Bras Med Trop, 40, 1, 10.1590/S0037-86822007000100001
Lana M, 2009, Clinical and laboratory status of patients with chronic Chagas disease living in a vector-controlled area in Minas Gerais, Brazil, before and nine years after aetiological treatment, Mem Inst Oswaldo Cruz, 104, 1139, 10.1590/S0074-02762009000800011
Pérez-Molina JA, 2009, Use of benznidazole to treat chronic Chagas' disease: a systematic review with a meta-analysis, J Antimicrob Chemother, 64, 1139, 10.1093/jac/dkp357
CarlierI Y, 2003, Congenital infection with T. cruzi: from mechanisms of transmission to strategies for diagnosis and control, Rev Soc Bras Med Trop, 36, 767, 10.1590/S0037-86822003000600024
Scapellato PG, 2009, Mother-child transmission of Chagas disease: could infection with human immunodeficiency virus increase the risk?, Rev Soc Bras Med Trop, 42, 107, 10.1590/S0037-86822009000200002
Bua J, 2012, Vertical transmission of Trypanosoma cruzi infection: quantification of parasite burden in mothers and their children by parasite DNA amplification, Trans R Soc Trop Med Hyg, 106, 623, 10.1016/j.trstmh.2012.03.015
Mallimaci MC, 2010, Early diagnosis of congenital infection, using shed scute phase antigen, in Ushuaia, Tierra del Fuego, Argentina, Am J Trop Med Hyg, 82, 55, 10.4269/ajtmh.2010.09-0219
Chippaux JP, 2010, Antibody drop in newborns congenitally infected by Trypanosoma cruzi treated with benznidazole, Trop Med Int Health, 15, 87
2010
Luquetti AO, 2000, Diagnóstico laboratorial da infecção pelo Trypanosoma cruzi, 344
Chiari E, 1992, Parasitological diagnosis, 153
Luquetti AO, 1997, Diagnóstico sorológico da doença de Chagas, 99
2007, Programa Nacional de Controle de Chagas. Doença de Chagas aguda: aspectos epidemiológicos, diagnóstico e tratamento: guia de consulta rápida para profissionais de saúde, Rev Patol Trop, 36, 1
2013, Recomendações sobre o diagnóstico parasitológico, sorológico e molecular para confirmação da doença de Chagas aguda e crônica, Rev Patol Trop, 42, 475
Luquetti AO, 2010, Diagnosis of Trypanosoma cruzi infection, 743
Camargo ME, 1974, Anti-Trypanosoma cruzi IgM antibodies as serological evidence of recent infection, Rev Inst Med Trop São Paulo, 16, 200
Chiari E, 1989, Hemocultures for the parasitological diagnosis of human chronic Chagas disease, Rev Soc Bras Med Trop, 22, 19, 10.1590/S0037-86821989000100004
Chiari E, 1997, Diagnóstico parasitológico da doença de Chagas, 85
Cerisola JA, 1974
Castro AM, 2002, Blood culture and polymerase chain reaction for the diagnosis of the chronic phase of human infection with Trypanosoma cruzi, Parasitol Res, 88, 894, 10.1007/s00436-002-0679-3
Camargo ME, 1992, Serological diagnosis: an appraisal of Chagas disease serodiagnosis, 165
Ferreira AW, 2001, Doença de Chagas, 2 ed, 241
2002
Hijar G, 2009
Schijman AG, 2011, International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients, PLoS Negl Trop Dis, 5, 10.1371/journal.pntd.0000931
Camargo ME, 1966, Fluorescent antibody test for the diagnosis of American trypanosomiasis. Technical modification employing preserved culture forms of Trypanosoma cruzi in a slide test, Rev Inst Med Trop São Paulo, 8, 227
Cerisola JA, 1962, Test de hemaglutinación para el diagnóstico de la enfermedad de Chagas, Prensa Méd Argent, 49, 1761
Voller A, 1975, Microplate enzyme-linked immunosorbent assay for Chagas disease, Lancet, 305, 426, 10.1016/S0140-6736(75)91492-0
Castro CN, 1983, Importância da repetição do xenodiagnóstico para avaliação da parasitemia na fase crônica da doença de Chagas, Rev Soc Bras Med Trop, 16, 98, 10.1590/S0037-86821983000200007
Junqueira AC, 1996, Comparison of the polymerase chain reaction with two classical parasitological methods for diagnosis of Chagas disease patients in a north-eastern endemic region of north-eastern Brazil, Trans R Soc Trop Med Hyg, 90, 129, 10.1016/S0035-9203(96)90111-X
Britto CC, 2009, Usefulness of PCR-based assays to assess drug efficacy in Chagas disease chemotherapy: value and limitations, Mem Inst Oswaldo Cruz, 104, 122, 10.1590/S0074-02762009000900018
Silveira JF, 2001, Chagas disease: recombinant Trypanosoma cruzi antigens for serological diagnosis, Trends Parasitol, 17, 286, 10.1016/S1471-4922(01)01897-9
Zicker F, 1990, Mass screening for Trypanosoma cruzi infections using the immunofluorescence, ELISA and haemagglutination tests on serum samples and on blood eluates from filter-paper, Bull World Health Organ, 68, 465
Sánchez-Camargo CL, 2014, 11 commercialized rapid diagnostic tests for detecting Trypanosoma cruzi antibodies in serum banks in areas of endemicity and nonendemicity, J Clin Microbiol, 52, 2506, 10.1128/JCM.00144-14
Pinto AYN, 2004, Emerging acute Chagas disease in Amazonian Brazil: case reports with serious cardiac involvement, Braz J Infect Dis, 8, 454
Dias JP, 2008, Acute Chagas disease outbreak associated with oral transmission, Rev Soc Bras Med Trop, 41, 296, 10.1590/S0037-86822008000300014
Pinto AY, 2013, Clinical follow-up of responses to treatment with benznidazol in Amazon: a cohort study of acute Chagas disease, Plos One, 8, 10.1371/journal.pone.0064450
2002, Chagas disease after organ transplantation: United States, 2001, MMWR Morb Mortal Wkly Rep, 51, 210
2006, Chagas disease after organ transplantation: Los Angeles, California, 2006, MMWR Morb Mortal Wkly Rep, 55, 798
Rocha A, 2006, Recomendações para diagnóstico, tratamento e acompanhamento da co-infecção Trypanosoma cruzi: vírus da imunodeficiência humana, Rev Soc Bras Med Trop, 39, 392, 10.1590/S0037-86822006000400017
Rassi A, 2000, Fase aguda, 2 ed, 231
Romaña C, 1935, 22, 16
Lugones HS, 2001
Ferreira HO, 1982, Estudo evolutivo da doença de Chagas com fase aguda conhecida, Rev Soc Bras Med Trop, 15, 125, 10.1590/S0037-86821982000100014
Ferreira HO, 1985
Parada H, 1997, Cardiac involvement is a constant finding in acute Chagas' disease: a clinical, parasitological and histopathological study, Int J Cardiol, 60, 49, 10.1016/S0167-5273(97)02952-5
Wendell S, 1997, Doença de Chagas transfusional, 411
Noya BA, 2010, Large urban outbreak of orally acquired acute Chagas disease at a school in Caracas, Venezuela, J Infect Dis, 201, 1308, 10.1086/651608
Shaw J, 1969, Considerações sobre a epidemiologia dos primeiros casos autóctones de doença de Chagas registrados em Belém, Pará, Brasil, Rev Saude Publica, 3, 153, 10.1590/S0034-89101969000200005
Pinto AYN, 2009, Urban outbreak of acute Chagas disease in Amazon region of Brazil: four-year follow-up after treatment with benznidazole, Rev Panam Salud Publica, 25, 77, 10.1590/S1020-49892009000100012
Shikanai-Yasuda MA, 1991, Possible oral transmission of acute Chagas disease in Brasil, Rev Inst Med Trop Sao Paulo, 33, 351, 10.1590/S0036-46651991000500003
Jörg ME, 1961, Lipochagomata genii or lipochagomata of the cheeks, characteristic lesions of acute trypanosomiasis cruzi in children under three years of age, Acta Trop, 18, 318
Medeiros MB, 2008, Meningoencephalitis in a patient with acute Chagas disease in the Brazilian Amazon, Rev Soc Bras Med Trop, 41, 520, 10.1590/S0037-86822008000500020
Freilij H, 1995, Perinatal human immunodeficiency virus infection and congenital Chagas' disease, Pediatr Infect Dis J, 14, 161, 10.1097/00006454-199502000-00021
Nisida IV, 1999, A survey of congenital Chagas' disease, carried out at three health institutions in São Paulo City, Brazil, Rev Inst Med Trop Sao Paulo, 41, 305, 10.1590/S0036-46651999000500007
Sartori AM, 2007, Manifestations of Chagas disease (American trypanosomiasis) in patients with HIV/AIDS, Ann Trop Med Parasitol, 101, 31, 10.1179/136485907X154629
França LCM, 1969, Moléstia de Chagas crônica associada à leucemia linfática: ocorrência de encefalite aguda como alteração do estado imunitário, Arq Neuro-Psiquiatr, 27, 59, 10.1590/S0004-282X1969000100005
Spina-França A, 1988, Anticorpos a Trypanosoma cruzi no líquido cefalorraqueano: pesquisa pelas reações de fixação do complemento e de imunofluorescência, Arq Neuro-Psiquiatr, 46, 374, 10.1590/S0004-282X1988000400006
Livramento JA, 1989, Anormalidades do líquido cefalorraqueano em 170 casos de AIDS, Arq Neuro-Psiquiatr, 47, 326, 10.1590/S0004-282X1989000300013
Del Castilho M, 1990, AIDS and Chagas' disease with central nervous system tumor-like lesion, Am J Med, 88, 693, 10.1016/0002-9343(90)90544-N
Ferreira MS, 1991, Acute fatal Trypanosoma cruzi meningoencephalitis in a human immunodeficiency virus-positive hemophiliac patient, Am J Trop Med Hyg, 45, 723, 10.4269/ajtmh.1991.45.723
Riarte A, 1999, Chagas' disease in patients with kidney transplants: 7 years of experience 1989-1996, Clin Infect Dis, 29, 561, 10.1086/598634
Campos SV, 2008, Risk factors for Chagas' disease reactivation after heart transplantation, J Heart Lung Transplant, 27, 597, 10.1016/j.healun.2008.02.017
2009, Portaria nº 2.600, de 21 de outubro de 2009. Aprova o Regulamento Técnico do Sistema Nacional de Transplantes, Diário Oficial da República Federativa do Brasil, 77
Altclas J, 2005, Chagas disease in bone marrow transplantation: an approach to preemptive therapy, Bone Marrow Transplant, 36, 123, 10.1038/sj.bmt.1705006
Barcán L, 2005, Transmission of T. cruzi infection via liver transplantation to a nonreactive recipient for Chagas' disease, Liver Transpl, 11, 1112, 10.1002/lt.20522
Rassi A, 1999, Protective effect of benznidazole against parasite reactivation in patients chronically infected with Trypanosoma cruzi and treated with corticoids for associated diseases, Rev Soc Bras Med Trop, 32, 475
Cordova E, 2008, Reactivation of Chagas disease with central nervous system involvement in HIV-infected patients in Argentina, 1992-2007, Int J Infect Dis, 12, 587, 10.1016/j.ijid.2007.12.007
1985, Validade do conceito de forma indeterminada de doença de Chagas, Rev Soc Bras Med Trop, 18, 46, 10.1590/S0037-86821985000100010
Dias JC, 1989, The indeterminate form of human chronic Chagas' disease: a clinical epidemiological review, Rev Soc Bras Med Trop, 22, 147, 10.1590/S0037-86821989000300007
Macêdo VO, 1997, Forma indeterminada da doença de Chagas, 135
Macêdo VO, 1999, Indeterminate form of Chagas disease, Mem Inst Oswaldo Cruz, 94, 311, 10.1590/S0074-02761999000700059
Ianni BM, 2001, Chagas' heart disease: evolutive evaluation of electrocardiographic and echocardiographic parameters in patients with the indeterminate form, Arq Bras Cardiol, 77, 59, 10.1590/S0066-782X2001000700006
Dias JCP, 2002, Doença de Chagas em Lassance, MG. Reavaliação clínico-epidemiológica 90 anos após a descoberta de Carlos Chagas, Rev Soc Bras Med Trop, 35, 167, 10.1590/S0037-86822002000200007
Almeida EA, 2007, Apresentação clínica da doença de Chagas crônica em indivíduos idosos, Rev Soc Bras Med Trop, 40, 311, 10.1590/S0037-86822007000300012
Villela E, 1923, Moléstia de Chagas: descrição clínica, 5ª parte, Folha Médica, 4, 65
Dias E, 1956, Chagas' disease: a clinical, epidemiologic and pathologic study, Circulation, 14, 1035, 10.1161/01.CIR.14.6.1035
Prata A, 1984, Morbidity of Chagas' heart disease, Mem Inst Oswaldo Cruz, 79, 93, 10.1590/S0074-02761984000500018
1974, Aspectos clínicos de la enfermedad de Chagas. Informe de una reunión conjunta OMS/OPAS de investigadores, Bol Oficina Sanit Panam, 76, 141
1974, 46 p
Oliveira Júnior W, 1990, Forma indeterminada da doença de Chagas: implicações médico-trabalhistas, Arq Bras Cardiol, 54, 89
Guariento ME, 1999, Working conditions of Chagas' disease patients in a large Brazilian city, Cad Saude Publica, 15, 381, 10.1590/S0102-311X1999000200022
Dias JCP, 2012, Doença de Chagas: diagnóstico e manejo na atenção primária à saúde, 2067
Castro I, 2011, Sociedade Brasileira de Cardiologia. I Diretriz Latino-Americana para o diagnóstico e tratamento da cardiopatia chagásica, Arq Bras Cardiol, 97, 1, 10.1590/S0066-782X2011001600001
Ozaki Y, 2011, Quality of life and depressive symptoms in Chagas disease patients, Qual Life Res, 20, 133, 10.1007/s11136-010-9726-1
Higuchi ML, 2003, Pathophysiology of the heart in Chagas' disease: current status and new developments, Cardiovasc Res, 60, 96, 10.1016/S0008-6363(03)00361-4
Higuchi ML, 1995, Chagas disease: importance of the parasite in the pathogenesis of the cardiac chronic disease, Arq Bras Cardiol, 64, 251
Higuchi ML, 1997, Chronic chagasic cardiopathy: the product of a turbulent host-parasite relationship, Rev Inst Med Trop Sao Paulo, 39, 53, 10.1590/S0036-46651997000100012
Marin-Neto JA, 2007, Pathogenesis of chronic Chagas heart disease, Circulation, 115, 1109, 10.1161/CIRCULATIONAHA.106.624296
Chagas C, 1922, Forma cardíaca da Trypanosomíase americana, Mem Inst Oswaldo Cruz, 14, 5, 10.1590/S0074-02761922000100001
Coura JR, 1985, Morbidity in Chagas' disease. IV. longitudinal study of 10 years in Pains and Iguatama, Minas Gerais, Brazil, Mem Inst Oswaldo Cruz, 80, 73, 10.1590/S0074-02761985000100011
Pereira Barretto AC, 1986, Right ventricular endomyocardial biopsy in chronic Chagas' disease, Am Heart J, 111, 307, 10.1016/0002-8703(86)90144-4
Prata A, 1986, Characteristics of unexpected sudden death in Chagas disease, Rev Soc Bras Med Trop, 19, 9
Dias JC, 1968, The prognostic value of the electrocardiographic features of chronic Chagas' disease, Rev Inst Med Trop Sao Paulo, 10, 158
Bestetti RB, 1997, Clinical course of Chagas' heart disease: a comparison with dilated cardiomyopathy, Int J Cardiol, 60, 187, 10.1016/S0167-5273(97)00083-1
Pinto AY, 2001, Cardiac attacks in patients with acute Chagas disease in a family micro-outbreak, in Abaetetuba, Brazilian Amazon, Rev Soc Bras Med Trop, 34, 413
Souza DSM, 2013, O eletrocardiograma na fase aguda da Doença de Chagas por transmissão oral, Rev Bras Cardiol, 26, 127
Nishioka SA, 1993, Reactivation of Chagas' disease successfully treated with benznidazole in a patient with acquired immunodeficiency syndrome, Mem Inst Oswaldo Cruz, 88, 493, 10.1590/S0074-02761993000300022
Almeida EA, 2009, Fatal evolution of Chagas' disease/Aids co-infection: diagnostic difficulties between myocarditis reactivation and chronic chagasic myocardiopathy, Rev Soc Bras Med Trop, 42, 199
Perez-Ramirez L, 1999, Clinical analysis and parasite genetic diversity in human immunodeficiency virus/Chagas' disease coinfections in Brazil, Am J Trop Med Hyg, 61, 198, 10.4269/ajtmh.1999.61.198
Bestetti RB, 1994, Noninvasive predictors of mortality for patients with Chagas' heart disease: a multivariate stepwise logistic regression study, Cardiology, 84, 261, 10.1159/000176409
Mady C, 1994, Survival and predictors of survival in patients with congestive heart failure due to Chagas' cardiomyopathy, Circulation, 90, 3098, 10.1161/01.CIR.90.6.3098
Rassi Júnior A, 2006, Development and validation of a risk score for predicting mortality in Chagas' heart disease, N Engl J Med, 355, 799, 10.1056/NEJMoa053241
Xavier SS, 2005, Application of the new classification of cardiac insufficiency (ACC/AHA) in chronic Chagas cardiopathy: a critical analysis of the survival curves, Rev SOCERJ, 18, 227
Rodriguez-Salas LA, 1998, Echocardiographic and clinical predictors of mortality in chronic Chagas' disease, Echocardiography, 15, 271, 10.1111/j.1540-8175.1998.tb00607.x
Viotti RJ, 2004, Value of echocardiography for diagnosis and prognosis of chronic Chagas' disease cardiomyopathy without heart failure, Heart, 90, 655, 10.1136/hrt.2003.018960
Acquatella H, 1980, M-mode and two-dimensional echocardiography in chronic Chagas' heart disease: a clinical and pathologic study, Circulation, 62, 787, 10.1161/01.CIR.62.4.787
Dias JCP, 1985, 99
Carrasco HA, 1994, Prognostic implications of clinical, electrocardiographic and hemodynamic findings in chronic Chagas' disease, Int J Cardiol, 43, 27, 10.1016/0167-5273(94)90087-6
Garzon SA, 1995, Electrocardiography in Chagas' heart disease, Sao Paulo Med J, 113, 802, 10.1590/S1516-31801995000200011
Marin-Neto JA, 1999, Chagas' heart disease, Arq Bras Cardiol, 72, 247
Almeida-Filho OC, 2002, Minor segmental dyssynergy reflects extensive myocardial damage and global left ventricle dysfunction in chronic Chagas disease, J Am Soc Echocardiogr, 15, 610, 10.1067/mje.2002.117845
Pazin-Filho A, 2007, Left ventricular global performance and diastolic function in indeterminate and cardiac forms of Chagas' disease, J Am Soc Echocardiogr, 20, 1338, 10.1016/j.echo.2007.04.029
Júnior Rassi A, 2007, Predictors of mortality in chronic Chagas disease: a systematic review of observational studies, Circulation, 115, 1101, 10.1161/CIRCULATIONAHA.106.627265
Xavier SS, 2005, Incidência e preditores de morte súbita na cardiopatia chagásica crônica com função sistólica preservada, Rev SOCERJ, 18, 457
Cunha GP, 1960, Síndromes clínicas na cardiomiopatia chagásica crônica, Hospital, 57, 71
Rassi Jr A, 2000, Estado da Arte. Cardiopatia chagásica crônica, Rev Soc Cardiol Est São Paulo, 10, 6
Rassi Júnior A, 1995, Arritmias ventriculares na doença de Chagas. Particularidades diagnósticas, prognósticas e terapêuticas, Arq Bras Cardiol, 65, 377
Rassi Júnior A, 2001, Morte súbita na Doença de Chagas, Arq Bras Cardiol, 76, 75
Rassi Júnior A, 1993, Arritmia ventricular na insuficiência cardíaca de etiologia chagásica e não chagásica, Arq Bras Cardiol, 61, 11
Scanavacca M, 1995, Electrophysiologic study in chronic Chagas' heart disease, Sao Paulo Med J, 113, 841, 10.1590/S1516-31801995000200016
Chiale PA, 1984, Efficacy of amiodarone during long-term treatment of malignant ventricular arrhythmias in patients with chronic chagasic myocarditis, Am Heart J, 107, 656, 10.1016/0002-8703(84)90311-9
Silva CP, 2006, Importance of amiodarone pulmonary toxicity in the differential diagnosis of a patient with dyspnea awaiting a heart transplant, Arq Bras Cardiol, 86, e4
Zimerman LI, 2009, Diretrizes brasileiras de fibrilação atrial, Arq Bras Cardiol, 92, 1
Martinelli Filho M, 2007, Diretrizes brasileiras de dispositivos eletrônicos implantáveis (DCEI), Arq Bras Cardiol, 89, e210, 10.1590/S0066-782X2007001800017
Baroldi G, 1997, Sudden and unexpected death in clinically 'silent' Chagas' disease. A hypothesis., Int J Cardiol, 58, 263, 10.1016/S0167-5273(96)02878-1
Marin-Neto JA, 1998, Aspectos peculiares da fisiopatologia da insuficiência cardíaca na doença de Chagas, Rev Soc Cardiol Est São Paulo, 8, 243
Simões MV, 2000, Insuficiência cardíaca na doença de Chagas, Rev Soc Cardiol Est São Paulo, 10, 50
Bocchi EA, 2012, Atualização da Diretriz Brasileira de Insuficiência Cardíaca Crônica, Arq Bras Cardiol, 98, 1, 10.1590/S0066-782X2012001000001
Rocha MOC, 2003, Clinical management of chronic Chagas cardiomyopathy, Front Biosci, 8, e44, 10.2741/926
Marin-Neto JA, 2008, BENEFIT Investigators. Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT), Am Heart J, 156, 37, 10.1016/j.ahj.2008.04.001
Morillo CA, 2015, BENEFIT Investigators. Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy, N Engl J Med, 373, 1295, 10.1056/NEJMoa1507574
Viotti R, 2006, Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial, Ann Intern Med, 144, 724, 10.7326/0003-4819-144-10-200605160-00006
Viotti R, 2005, Clinical predictors of chronic chagasic myocarditis progression, Rev Esp Cardiol, 58, 1037
Marin-Neto JA, 2014, Doença de Chagas: moléstia negligenciada, 117
Montera MW, 2012, Sumário de Atualização da II Diretriz Brasileira de Insuficiência Cardíaca Aguda: 2009/2011, Arq Bras Cardiol, 98, 375, 10.1590/S0066-782X2012000500001
Roberti RR, 1992, Chagas cardiomyopathy and captopril, Eur Heart J, 13, 966, 10.1093/oxfordjournals.eurheartj.a060301
Davila DF, 2002, Effects of metoprolol in chagasic patients with severe congestive heart failure, Int J Cardiol, 85, 255, 10.1016/S0167-5273(02)00181-X
Freitas H, 1999, Betablockers for Chagas' heart disease, J Am Coll Cardiol, 33, 184
Bocchi EA, 1993, Long-term follow-up after heart transplantation in Chagas' disease, Transplant Proc, 25, 1329
Carvalho VB, 1996, Heart transplantation in Chagas' disease. 10 Years after the initial experience, Circulation, 94, 1815, 10.1161/01.CIR.94.8.1815
Ribeiro dos Santos R, 2012, Chagas Arm of the MiHeart Study Investigators. Cell therapy in Chagas cardiomyopathy (Chagas arm of the multicenter randomized trial of cell therapy in cardiopathies study): a multicenter randomized trial, Circulation, 125, 2454, 10.1161/CIRCULATIONAHA.111.067785
Samuel J, 1983, Cardiac thrombosis and thromboembolism in chronic Chagas' heart disease, Am J Cardiol, 52, 147, 10.1016/0002-9149(83)90085-1
Lopes ER, 1991, Associação entre acidentes vasculares encefálicos e doença de Chagas, Rev Soc Bras Med Trop, 24, 101, 10.1590/S0037-86821991000200006
Sousa AS, 2008, Prevention strategies of cardioembolic ischemic stroke in Chagas' disease, Arq Bras Cardiol, 91, 306
Oliveira Júnior W, 1997, O cardiopata chagásico em situações especiais, 2 ed, 293
Bestetti RB, 1997, Avaliação do risco cirúrgico em pacientes portadores de cardiopatia chagásica crônica em cirurgias não cardíacas, 2 ed, 281
Ramos G, 2003, Marcapasso cardíaco artificial: considerações pré e per-operatórias, Rev Bras Anestesiol, 53, 854, 10.1590/S0034-70942003000600015
Prata A, 1973, Implicações epidemiológicas e sócio-econômicas da doença de Chagas, Brasilia Med, 9, 69
Porto CC, 1985, Aspectos sócio-econômicos e médico-trabalhistas, 362
Dias JCP, 1999, Aspectos clínicos, sociais e trabalhistas da doença de Chagas em área endêmica sob controle do estado de Minas Gerais, Brasil, Rev Soc Bras Med Trop, 26, 93, 10.1590/S0037-86821993000200005
Morais BB, 1991, Concomitant lesions in Chagas' disease, Eur J Gastroenterol Hepatol, 3, 523
Fonseca FM, 2014, Histological and endoscopic features of the stomachs of patients with Chagas disease in the era of Helicobacter pylori, Rev Soc Bras Med Trop, 47, 739, 10.1590/0037-8682-0180-2014
Rezende JM, 1982, Classificação radiológica do megaesôfago, Rev Goiana Med, 28, 187
Brücher BL, 2001, Achalasia and esophageal cancer: incidence, prevalence, and prognosis, World J Surg, 25, 745, 10.1007/s00268-001-0026-3
Leeuwenburgh I, 2010, Long-term esophageal cancer risk in patients with primary achalasia: a prospective study, Am J Gastroenterol, 105, 2144, 10.1038/ajg.2010.263
Pérez-Ayala A, 2011, Gastro-intestinal Chagas disease in migrants to Spain: prevalence and methods for early diagnosis, Ann Trop Med Parasitol, 105, 25, 10.1179/136485910X12851868780423
Oliveira RB, 1998, Gastrointestinal manifestations of Chagas disease, Am J Gastroenterol, 93, 884, 10.1016/S0002-9270(98)00151-8
Meier-Ruge WA, 2006, The pathogenesis of idiopathic megacolon, Eur J Gastroenterol Hepatol, 18, 1209, 10.1097/01.meg.0000236883.13720.c2
Pasricha PJ, 1996, Botulinum toxin for achalasia: long-term outcome and predictors of response, Gastroenterology, 110, 1410, 10.1053/gast.1996.v110.pm8613045
Ferguson MK, 1991, Achalasia: current evaluation and therapy, Ann Thorac Surg, 52, 336, 10.1016/0003-4975(91)91373-4
Heller E, 1913, Extramukose Cardiaplastik beim chronischen Cardiospasmus mit Dilatation des Oesophagus, Mitt Grenzgeb Med Chir, 27, 141
Pinotti HW, 1993, The surgical treatment of megaesophagus and megacolon, Dig Dis, 11, 206, 10.1159/000171413
Spiess AE, 1998, Treating achalasia: from whalebone to laparoscope, JAMA, 280, 638, 10.1001/jama.280.7.638
Stavropoulos SN, 2014, Per-oral endoscopic myotomy white paper summary, Gastrointest Endosc, 80, 1, 10.1016/j.gie.2014.04.014
Inoue H, 2011, Peroral endoscopic myotomy for esophageal achalasia: technique, indication, and outcomes, Thorac Surg Clin, 21, 519, 10.1016/j.thorsurg.2011.08.005
Swanstrom LL, 2012, Long-term outcomes of an endoscopic myotomy for achalasia: the POEM procedure, Ann Surg, 256, 659, 10.1097/SLA.0b013e31826b5212
Duhamel B, 1956, Une nouvelle opération pour le mégacolon cologénital: l'abaissement rétro-rectal et transanal du côlon et son application possible au traitement de quelques autres malformations, Nouv Presse Med, 64, 2249
Reis-Neto JA, 2004, Megacolo adquirido: perspectivas fisiopatológicas para o tratamento laparoscópico, Rev Bras Colo-proctol, 24, 49
Coura JR, 2011, Chronic phase of Chagas disease: why should it be treated? A comprehensive review, Mem Inst Oswaldo Cruz, 106, 641, 10.1590/S0074-02762011000600001
Molina I, 2014, Randomized trial of posaconazole and benznidazole for chronic Chagas' disease, N Engl J Med, 370, 1899, 10.1056/NEJMoa1313122
Cançado JR, 1997, 323
Sosa Estani S, 1988, Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas' disease, Am J Trop Med Hyg, 59, 526, 10.4269/ajtmh.1998.59.526
Andrade AL, 1996, Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection, Lancet, 348, 1407, 10.1016/S0140-6736(96)04128-1
Yun O, 2009, Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolivia: 10-year experience of Médecins Sans Frontières, PLoS Negl Trop Dis, 3
Bern C, 2007, Evaluation and treatment of Chagas disease in the United States: a systematic review, JAMA, 298, 2171, 10.1001/jama.298.18.2171
Coura JR, 1997, Comparative controlled study on the use of benznidazole, nifurtimox and placebo, in the chronic form of Chagas' disease, in a field area with interrupted transmission. I. Preliminary evaluation, Rev Soc Bras Med Trop, 30, 139
Bitto C, 2001, Parasite persistence in treated chagasic patients revealed by xenodiagnosis and polymerase chain reaction, Mem Inst Oswaldo Cruz, 96, 823, 10.1590/S0074-02762001000600014
Gallerano RH, 2001, Resultados de un estúdio a largo plazo con drogas antiparasitárias en infectados chagásicos crónicos, Rev Fed Arg Cardiol, 30, 289
Fragata Filho AA, 2009, Tratamento antiparasitário da doença de Chagas, Rev Soc Cardiol Estado de São Paulo, 19, 2
Andrade SG, 1989, Terapêutica da fase crônica da infecção experimental pelo Trypanosoma cruzi com o benzonidazol e o nifurtimox, Rev Soc Bras Med Trop, 22, 113, 10.1590/S0037-86821989000300001
Garcia S, 2005, Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations, Antimicrob Agents Chemother, 49, 1521, 10.1128/AAC.49.4.1521-1528.2005
Coura JR, 2002, A critical review on Chagas disease chemotherapy, Mem Inst Oswaldo Cruz, 97, 3, 10.1590/S0074-02762002000100001
Maguire JH, 2015, Treatment of Chagas' disease: time is running out, N Engl J Med, 373, 1369, 10.1056/NEJMe1510170
D'Albuquerque LA, 2007, Liver transplantation from deceased donors serologically positive for Chagas disease, Am J Transplant, 7, 680, 10.1111/j.1600-6143.2007.01663.x
Altclas JD, 2008, Organ transplantation and Chagas disease, JAMA, 299, 1134, 10.1001/jama.299.10.1134-a
Sousa AA, 2004, Chagas seropositive donors in kidney transplantation, Transplant Proc, 36, 868, 10.1016/j.transproceed.2004.03.113
Bocchi EA, 1996, Heart transplantation for chronic Chagas' disease, Ann Thorac Surg, 61, 1727, 10.1016/0003-4975(96)00141-5
Freitas VL, 2011, Real-time PCR in HIV/Trypanosoma cruzi coinfection with and without Chagas disease reactivation: association with HIV viral load and CD4 level, PLoS Negl Trop Dis, 5, 10.1371/journal.pntd.0001277
Brener Z, 1984, Laboratory-acquired Chagas' disease: an endemic disease among parasitologists?, 2 ed, 3
Brener Z, 1987, Laboratory-acquired Chagas disease: comment, Trans R Soc Trop Med Hyg, 81, 527, 10.1016/0035-9203(87)90197-0
Shikanai-Yasuda MA, 1993, Doença de Chagas aguda após uso profilático de benznidazol (Acidente de laboratório), Rev Soc Bras Med Tropical, 26, 127